Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Univariate analysis revealed that the presence of diabetes mellitus, history of fragility fracture, glucocorticoid use for ≥ 6 months, femoral neck BMD T-score, serum PINP, serum β-CTX, serum 25(OH)D, and serum OC were associated with poor treatment response (P < 0.05) (Table 2).

Source: Univariate analysis of osteoporosis treatment efficacy. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were randomly allocated to a training set (n = 380) and a validation set (n = 163) in a 7:3 ratio.

Source: Abstract.

This single-center retrospective cohort study consecutively enrolled patients diagnosed with primary osteoporosis who initiated standard anti-osteoporosis treatment at osteoporosis specialty clinic or orthopedics inpatient department of the Third Affiliated Hospital, Guangzhou Medical University, and the Fifth Affiliated Hospital, Guangzhou Medical University between January 2021 and December 2024.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Predicting poor response to anti-osteoporosis therapy: a machine learning model integrating clinical and novel biomarker data

Cohort study · Frontiers in Medicine · 2026

Original publication title

Predicting poor response to anti-osteoporosis therapy: a machine learning model integrating clinical and novel biomarker data

Yannan Bi; Maolin Zhang; Weiqiong Zhang; Jiahong Li

Copyright © 2026 Bi, Zhang, Zhang and Li.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

A predictive model integrating multi-dimensional factors was successfully developed and validated for assessing osteoporosis treatment efficacy. The RF-based model exhibited robust predictive performance and clinical utility. It shows potential for pre-therapeutic identification of high-risk patients, facilitating precision management in osteoporosis.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This study was conducted to develop and validate a prediction model integrating clinical characteristics and novel biomarkers. The goal was to identify patients at high risk for a poor response to standard anti-osteoporosis therapy prior to treatment initiation, thereby supporting personalized therapeutic decision-making.

Source: Objective

Abstract: What methods does the paper describe?

A retrospective analysis was performed on 543 patients with primary osteoporosis admitted between January 2021 and December 2024. All patients received 12 months of standard treatment. Participants were randomly allocated to a training set (n = 380) and a validation set (n = 163) in a 7:3 ratio. In the training set, univariate analysis, Least Absolute Shrinkage and Selection Operator (LASSO) regression, and multivariate logistic regression were used to determine independent predictors. Three machine learning models: Random Forest (RF), Support Vector Machine (SVM), and K-Nearest Neighbors (KNN): were then constructed.

Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). SHapley Additive exPlanations (SHAP) values were used to interpret the optimal model.

Source: Methods

Abstract: Results

Baseline characteristics were comparable between the training and validation sets (P > 0.05). Eight independent predictors of poor treatment response were identified: comorbid diabetes, history of fragility fracture, glucocorticoid use for ≥ 6 months, femoral neck bone mineral density T-score, and serum levels of osteocalcin, procollagen type I N-terminal propeptide, β-CrossLaps of type I collagen (β-CTX), and 25-Hydroxyvitamin D. Among the models, the RF algorithm demonstrated superior performance, with an AUC of 0.856 (95% CI: 0.808 to 0.905) in the training set and 0.825 (95% CI: 0.718 to 0.933) in the validation set.

The model was well-calibrated, and DCA indicated a high net benefit. SHAP analysis confirmed serum β-CTX as the most significant predictive variable.

Source: Results

Abstract: Conclusion

A predictive model integrating multi-dimensional factors was successfully developed and validated for assessing osteoporosis treatment efficacy. The RF-based model exhibited robust predictive performance and clinical utility. It shows potential for pre-therapeutic identification of high-risk patients, facilitating precision management in osteoporosis.

Source: Conclusion
Authors’ abstract

Objective

This study was conducted to develop and validate a prediction model integrating clinical characteristics and novel biomarkers. The goal was to identify patients at high risk for a poor response to standard anti-osteoporosis therapy prior to treatment initiation, thereby supporting personalized therapeutic decision-making.

Methods

A retrospective analysis was performed on 543 patients with primary osteoporosis admitted between January 2021 and December 2024. All patients received 12 months of standard treatment. Participants were randomly allocated to a training set (n = 380) and a validation set (n = 163) in a 7:3 ratio. In the training set, univariate analysis, Least Absolute Shrinkage and Selection Operator (LASSO) regression, and multivariate logistic regression were used to determine independent predictors. Three machine learning models: Random Forest (RF), Support Vector Machine (SVM), and K-Nearest Neighbors (KNN): were then constructed.

Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). SHapley Additive exPlanations (SHAP) values were used to interpret the optimal model.

Results

Baseline characteristics were comparable between the training and validation sets (P > 0.05). Eight independent predictors of poor treatment response were identified: comorbid diabetes, history of fragility fracture, glucocorticoid use for ≥ 6 months, femoral neck bone mineral density T-score, and serum levels of osteocalcin, procollagen type I N-terminal propeptide, β-CrossLaps of type I collagen (β-CTX), and 25-Hydroxyvitamin D. Among the models, the RF algorithm demonstrated superior performance, with an AUC of 0.856 (95% CI: 0.808 to 0.905) in the training set and 0.825 (95% CI: 0.718 to 0.933) in the validation set.

The model was well-calibrated, and DCA indicated a high net benefit. SHAP analysis confirmed serum β-CTX as the most significant predictive variable.

Conclusion

A predictive model integrating multi-dimensional factors was successfully developed and validated for assessing osteoporosis treatment efficacy. The RF-based model exhibited robust predictive performance and clinical utility. It shows potential for pre-therapeutic identification of high-risk patients, facilitating precision management in osteoporosis.

Publication and source details

Original title: Predicting poor response to anti-osteoporosis therapy: a machine learning model integrating clinical and novel biomarker data

Yannan Bi; Maolin Zhang; Weiqiong Zhang; Jiahong Li

Frontiers in Medicine · 2026

* Correspondence: Maolin Zhang, gysy1220@163.comCopyright © 2026 Bi, Zhang, Zhang and Li.2026Bi, Zhang, Zhang and Lihttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:32:03.213156+00:00

DOI: 10.3389/fmed.2026.1786209 · PMC13216482